Allscripts (NASDAQ: MDRX) reported Q3 EPS of $0.18, $0.02 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $536 million versus the consensus estimate of $548.93 million.

GUIDANCE:

Allscripts sees FY2018 EPS of $0.72-$0.82, versus the consensus of $0.76. Allscripts sees FY2018 revenue of $2.15-2.25 million, versus the consensus of $2.17 million.

For earnings history and earnings-related data on Allscripts (MDRX) click here.